Success Story: NIW Approved! Assistant Professor Achieves a Major Milestone with Our Support
Client’s Testimonial:
“I had an excellent experience with NAILG and would highly recommend them. They were always quick to respond to questions and very easy to work with throughout the process. If needed, I would use them again for other services.”
On March 26th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Professor in the Field of Epilepsy (Approval Notice).
General Field: Epilepsy
Position at the Time of Case Filing: Assistant Professor
Approval Notice Date: March 26th, 2025
Processing Time: 10 months, 23 days
Case Summary:
North America Immigration Law Group (NAILG) is pleased to announce the approval of an I-140 EB2-NIW (National Interest Waiver) petition for our client, a physician-scientist with a research focus on epilepsy and related neurological conditions. After evaluating his credentials and innovative research, we determined that his work holds clear substantial merit and national importance, making him an excellent fit for the EB2-NIW category. Following our meticulous preparation of his petition, USCIS approved his case within eleven months of filing.
Advancing the Diagnosis and Treatment of Epilepsy
Our client’s proposed endeavor is centered on enhancing the methods used to diagnose and treat epilepsy and related conditions, such as psychogenic non-epileptic seizures (PNES) and psychiatric comorbidities like depression and anxiety. With a combined background in clinical medicine and neuroscience research, he is developing more accurate diagnostic protocols and pioneering clinical studies to evaluate novel therapies. These efforts contribute directly to addressing the widespread burden of epilepsy, which affects millions of Americans and is associated with high rates of misdiagnosis and inadequate treatment.
We highlighted how his work aligns with national public health goals by improving patient care, reducing diagnostic uncertainty, and optimizing mental health outcomes for individuals suffering from epilepsy. His research fills a crucial gap in neurological care by bridging clinical insight with evidence-based advancements in diagnostics and therapeutics.
Outstanding Credentials Supporting National Impact
To demonstrate the client’s qualifications and the significance of his contributions, NAILG compiled a compelling evidentiary record, including:
- 21 peer-reviewed journal articles and 1 book chapter, with a strong emphasis on first-authored work in top neurology and epilepsy journals.
- 178 citations, including multiple papers ranked among the top 10% most cited in the field of Clinical Medicine for their publication years, indicating the considerable influence of his work.
- 23 completed peer reviews for leading scientific publications, underscoring his role as a trusted expert evaluating cutting-edge research.
- Evidence of global adoption of his findings, with fellow researchers in neuroscience, stroke care, and psychiatric epidemiology building upon his data to support new treatments and policy recommendations.
Expert Support from the Scientific Community
To strengthen the petition further, we submitted 2 recommendation letters from established experts in epilepsy and neurology. These letters confirmed the transformative nature of his research and its far-reaching impact in enhancing epilepsy care.
“His achievements demonstrate [Client’s] instrumental contributions toward elevating epilepsy care through enhanced diagnostic precision. Hence, he must be allowed to continue this important work in the U.S.”
A Strong Case Built on Merit and Impact
Thanks to the comprehensive petition package prepared by NAILG and the client’s outstanding record of scientific achievement, USCIS approved this EB2-NIW petition without a Request for Evidence. The client’s unique integration of medical practice and research innovation in epilepsy positions him to continue making nationally significant contributions to neurological health in the United States.
We are proud to have supported this dedicated physician-researcher and look forward to his continued advancements in epilepsy diagnosis and treatment.